Cognitive Remediation in Middle-Aged or Older Inpatients with Chronic Schizophrenia: A Randomized Controlled Trial in Korea

Frontiers in Psychology
Kee-Hong ChoiTae-Yeon Hwang

Abstract

Background: Accumulating evidence indicates that cognitive remediation (CR) is effective for improving various cognitive deficits in adult patients with schizophrenia. Although reports of brain plasticity in older adults and the service needs for chronic patients with schizophrenia are increasing, very few randomized controlled trials of CR have been conducted in middle-aged or older inpatients with chronic schizophrenia. We investigated the efficacy of individualized CR on the cognitive impairments of middle-aged or older inpatients with chronic schizophrenia within the context of comprehensive psychiatric rehabilitation (PR) by comparing the results obtained with PR only and treatment as usual (TAU).Method:Fifty-seven middle-aged and older individuals with chronic schizophrenia and mild to moderate cognitive deficits were enrolled. Thirty-eight who were undergoing PR were randomly assigned to CR + PR (N= 19) or PR-only (N= 19) groups. Nineteen participants who were undergoing TAU without CR or PR were evaluated pre- and post-treatment.Results:CR was easily provided and well received (drop-out rates = 5.3%) by middle-aged or older psychiatric inpatients. Compared to the PR-Only or TAU patients, patients in the CR + PR group sh...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Mar 1, 1996·The American Journal of Psychiatry·M F Green
Mar 21, 1998·Schizophrenia Bulletin·A MedaliaA E Merriam
Jul 23, 1999·Schizophrenia Bulletin·W D SpauldingM Lam
Jul 23, 1999·Schizophrenia Bulletin·M F Green, K H Nuechterlein
Feb 10, 2000·Schizophrenia Bulletin·W D SpauldingM Weiler
Aug 3, 2000·Journal of Clinical and Experimental Neuropsychology·K Arbuthnott, J Frank
Nov 30, 2000·Psychological Medicine·A MedaliaM Casey
May 17, 2001·Schizophrenia Bulletin·A MedaliaM Casey
Jan 10, 2002·The Clinical Neuropsychologist·D S Kreiner, J J Ryan
Jun 6, 2002·Schizophrenia Bulletin·Mark van der GaagRobert P Liberman
Jan 25, 2003·Psychopharmacology·Lydia Krabbendam, André Aleman
Nov 9, 2004·Schizophrenia Research·Michael F GreenRobert K Heaton
Feb 11, 2005·Acta Psychiatrica Scandinavica·T Ueland, B R Rund
May 12, 2005·Schizophrenia Research·Gudrun SartoryKlaus Windgassen
May 13, 2005·Schizophrenia Bulletin·Roland VauthRainer Vater
Aug 26, 2006·Schizophrenia Research·Richard S E KeefeJeffery A Lieberman
Dec 21, 2006·JAMA : the Journal of the American Medical Association·Sherry L WillisUNKNOWN ACTIVE Study Group
Feb 8, 2007·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Julie Blaskewicz BoronK Warner Schaie
Mar 3, 2007·The American Journal of Psychiatry·Susan R McGurkAlysia Pascaris
Aug 8, 2007·Journal of Psychosocial Nursing and Mental Health Services·Paul H Lysaker, Kelly D Buck
Oct 19, 2007·Journal of Rehabilitation Research and Development·Morris BellGary Bryson
Dec 7, 2007·The American Journal of Psychiatry·Susan R McGurkKim T Mueser
Jan 24, 2008·Schizophrenia Bulletin·Steven M SilversteinHannah Starobin
Mar 1, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Jean-Pierre LindenmayerHaiyi Xie
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Christopher R Bowie, Philip D Harvey
Nov 10, 2009·Behavior Research Methods·Franz FaulAlbert-Georg Lang
Dec 17, 2009·The American Journal of Psychiatry·Dwight DickinsonAlan S Bellack
Apr 22, 2010·Nature·Adrian M OwenClive G Ballard
Mar 17, 2011·The American Journal of Psychiatry·Til WykesPál Czobor
Sep 1, 2011·Schizophrenia Bulletin·Til Wykes, Will D Spaulding
Oct 3, 2012·Handbook of Experimental Pharmacology·Richard S E Keefe, Philip D Harvey
Feb 12, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Dimitris KontisTil Wykes
Aug 15, 2013·European Archives of Psychiatry and Clinical Neuroscience·Dieter SchoepfReinhard Heun
Aug 21, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Stephen J BartelsJames Feldman
Jan 3, 2014·Psychiatric Services : a Journal of the American Psychiatric Association·Morris D BellBruce E Wexler
Jan 21, 2015·Psychiatry and Clinical Neurosciences·Toshiya Inada, Ataru Inagaki
Aug 8, 2015·The Clinical Neuropsychologist·Sung-Geon KimJi-Hae Kim

❮ Previous
Next ❯

Citations

Oct 20, 2018·Frontiers in Psychiatry·Eun Jin KimKee-Hong Choi

❮ Previous
Next ❯

Software Mentioned

Power
PSSCogRehab

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.